Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9328) 9328
Book Chapter (319) 319
Newspaper Article (114) 114
Magazine Article (30) 30
Newsletter (17) 17
Book / eBook (7) 7
Dissertation (4) 4
Trade Publication Article (4) 4
Reference (3) 3
Conference Proceeding (2) 2
Report (2) 2
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (7141) 7141
life sciences & biomedicine (6728) 6728
humans (6515) 6515
insulin (4348) 4348
male (3992) 3992
female (3539) 3539
diabetes (3411) 3411
endocrinology & metabolism (3182) 3182
insulin resistance (2683) 2683
glucose (2386) 2386
biological and medical sciences (2358) 2358
adult (2279) 2279
animals (2222) 2222
medical sciences (2105) 2105
middle aged (1990) 1990
blood glucose - metabolism (1723) 1723
insulin - administration & dosage (1625) 1625
diabetes mellitus (1530) 1530
diabetes mellitus, type 1 - drug therapy (1377) 1377
insulin - therapeutic use (1317) 1317
hypoglycemic agents - therapeutic use (1273) 1273
abridged index medicus (1261) 1261
type 2 diabetes (1251) 1251
hypoglycemic agents - administration & dosage (1203) 1203
obesity (1166) 1166
hyperglycemia (1163) 1163
aged (1132) 1132
risk factors (1102) 1102
endocrinopathies (1089) 1089
research (1079) 1079
insulin - blood (1049) 1049
metabolism (1020) 1020
type 1 diabetes (1012) 1012
care and treatment (1009) 1009
hypoglycemia (1009) 1009
insulin - adverse effects (980) 980
health aspects (955) 955
diabetes mellitus, type 2 - drug therapy (926) 926
endocrine pancreas. apud cells (912) 912
physiological aspects (910) 910
adolescent (899) 899
diabetes. impaired glucose tolerance (897) 897
hypoglycemic agents - adverse effects (859) 859
dextrose (853) 853
blood glucose - analysis (850) 850
treatment outcome (839) 839
analysis (821) 821
diabetes mellitus, type 1 - blood (817) 817
insulin - metabolism (814) 814
medicine & public health (771) 771
blood glucose - drug effects (728) 728
diabetes therapy (717) 717
insulin infusion systems (715) 715
etiopathogenesis. screening. investigations. target tissue resistance (702) 702
child (685) 685
internal medicine (669) 669
rats (640) 640
glucose metabolism (638) 638
fundamental and applied biological sciences. psychology (626) 626
review (620) 620
hypoglycemia - chemically induced (614) 614
rodents (613) 613
patients (599) 599
pharmacology & pharmacy (568) 568
mice (567) 567
pharmacology. drug treatments (559) 559
young adult (558) 558
metabolic diseases (555) 555
blood sugar (547) 547
insulin resistance - physiology (537) 537
general & internal medicine (533) 533
time factors (533) 533
medicine (531) 531
studies (525) 525
physiology (524) 524
clinical trials (523) 523
drug therapy (523) 523
inflammation (522) 522
cardiovascular system & cardiology (518) 518
insulin infusion systems - adverse effects (516) 516
glucose - metabolism (496) 496
body mass index (494) 494
proteins (490) 490
pregnancy (489) 489
mortality (485) 485
diabetes mellitus, type 2 - blood (481) 481
diet (478) 478
nutrition & dietetics (476) 476
pediatrics (470) 470
body weight (439) 439
research article (435) 435
endocrinology (421) 421
usage (413) 413
medicine, general & internal (411) 411
homeostasis (404) 404
hypoglycemia - prevention & control (404) 404
cardiovascular disease (401) 401
cardiac & cardiovascular systems (398) 398
insulin secretion (395) 395
science & technology - other topics (393) 393
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9755) 9755
French (32) 32
German (31) 31
Japanese (17) 17
Portuguese (14) 14
Spanish (9) 9
Norwegian (8) 8
Chinese (5) 5
Russian (4) 4
Czech (3) 3
Italian (3) 3
Swedish (3) 3
Finnish (2) 2
Polish (2) 2
Croatian (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline
by Peters, Anne L and Ahmann, Andrew J and Battelino, Tadej and Evert, Alison and Hirsch, Irl B and Murad, M. Hassan and Winter, William E and Wolpert, Howard
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 11/2016, Volume 101, Issue 11, pp. 3922 - 3937
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Endocrinology - methods | Drug Monitoring - trends | Combined Modality Therapy - trends | Humans | Diabetes Mellitus, Type 2 - diet therapy | Diabetes Mellitus, Type 1 - therapy | Hypoglycemia - prevention & control | Exercise | Monitoring, Ambulatory - trends | Hypoglycemic Agents - administration & dosage | Monitoring, Ambulatory - adverse effects | Diabetes Mellitus, Type 2 - therapy | Adult | Hypoglycemia - chemically induced | Patient Education as Topic | Precision Medicine | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Blood Glucose - analysis | Insulin Infusion Systems - adverse effects | Insulin - administration & dosage | Combined Modality Therapy - adverse effects | Evidence-Based Medicine | Consensus | Insulin Infusion Systems - trends | Diabetes Mellitus, Type 1 - drug therapy | Diabetes Mellitus, Type 2 - blood | International Agencies | Diabetes Mellitus, Type 1 - blood | Societies, Scientific | Diabetes Mellitus, Type 1 - diet therapy | Diet, Diabetic - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Cost‐effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review
by Roze, S and Smith‐Palmer, J and Valentine, W and Portu, S and Nørgaard, K and Pickup, J. C
Diabetic medicine, ISSN 0742-3071, 11/2015, Volume 32, Issue 11, pp. 1415 - 1424
Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Insulin - economics | Quality-Adjusted Life Years | Hyperglycemia - prevention & control | Hypoglycemic Agents - economics | Humans | Insulin Infusion Systems - adverse effects | Insulin - administration & dosage | Diabetes Mellitus, Type 1 - complications | Diabetes Complications - economics | Evidence-Based Medicine | Diabetes Mellitus, Type 1 - drug therapy | Hypoglycemia - prevention & control | Health Care Costs | Hypoglycemic Agents - administration & dosage | Diabetes Mellitus, Type 1 - economics | Cost-Benefit Analysis | Diabetes Mellitus, Type 1 - blood | Insulin Infusion Systems - economics | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin - therapeutic use | Diabetes Complications - prevention & control | Type 1 diabetes | Health aspects | Insulin | Analysis | Medical care, Cost of | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Nonmetabolic Complications of Continuous Subcutaneous Insulin Infusion: A Patient Survey
by Pickup, John C and Yemane, Nardos and Brackenridge, Anna and Pender, Siobhan
Diabetes technology & therapeutics, ISSN 1520-9156, 03/2014, Volume 16, Issue 3, pp. 145 - 149
Original Articles | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hypertrophy - etiology | Hypertrophy - prevention & control | Prevalence | Humans | Risk Factors | Self Report | Adipose Tissue - pathology | Insulin Infusion Systems - adverse effects | Insulin - administration & dosage | Male | Treatment Outcome | Injections, Subcutaneous - adverse effects | Diabetes Mellitus, Type 1 - drug therapy | Hypoglycemic Agents - administration & dosage | Adipose Tissue - injuries | Adult | Female | Surveys and Questionnaires | Odds Ratio | Weight Gain | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Health Care Surveys | Surveys | Dosage and administration | Research | Patient satisfaction | Insulin | Confidence intervals | Diabetes | Patients | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group
by Heinemann, Lutz and Heinemann, Lutz and Fleming, G Alexander and Fleming, G. Alexander and Petrie, John R and Petrie, John R and Holl, Reinhard W and Holl, Reinhard W and Bergenstal, Richard M and Bergenstal, Richard M and Peters, Anne L and Peters, Anne L
Diabetes care, ISSN 0149-5992, 04/2015, Volume 38, Issue 4, pp. 716 - 722
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Diabetes Mellitus, Type 1 - epidemiology | Hypoglycemia - epidemiology | Risk Assessment | Adverse Drug Reaction Reporting Systems | United States | Europe | Humans | Insulin Infusion Systems - adverse effects | Insulin - administration & dosage | Diabetes Mellitus, Type 1 - drug therapy | Hypoglycemia - etiology | Insulin Infusion Systems - standards | Device Approval - standards | Hyperglycemia - epidemiology | Hyperglycemia - etiology | Insulin - adverse effects | Medical Device Recalls | Equipment Failure | Diabetes | Hypoglycemia | Insulin | Risk assessment | Manufacturers | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trial
by Hoogma, R. P. L. M and Hammond, P. J and Gomis, R and Kerr, D and Bruttomesso, D and Bouter, K. P and Wiefels, K. J and De La Calle, H and Schweitzer, D. H and Pfohl, M and Torlone, E and Krinelke, L. G and Bolli, G. B and 5-Nations Study Grp and 5-Nations Study Group and on behalf of the 5-Nations Study Group1
Diabetic medicine, ISSN 0742-3071, 02/2006, Volume 23, Issue 2, pp. 141 - 147
continuous subcutaneous insulin infusion | Type 1 diabetes mellitus | multiple daily injections | quality of life | hypoglycaemia | Multiple daily injections | Hypoglycaemia | Continuous subcutaneous insulin infusion | Quality of life | Type 1 diabetes mellitus | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Diabetes. Impaired glucose tolerance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Glycated Hemoglobin A - analysis | Blood Glucose - analysis | Drug Administration Schedule | Humans | Insulin Infusion Systems - adverse effects | Insulin - administration & dosage | Male | Treatment Outcome | Diabetes Mellitus, Type 1 - complications | Diabetes Mellitus, Type 1 - drug therapy | Cross-Over Studies | Injections - adverse effects | Diabetes Mellitus, Type 1 - blood | Hypoglycemia - complications | Quality of Life | Adult | Female | Body Weight - physiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events
: Results From a Prospective Randomized Crossover Study
by Pfützner, Andreas and Sachsenheimer, Daniela and Grenningloh, Marco and Heschel, Matthias and Walther-Johannesen, Lene and Gharabli, Rabi and Klonoff, David
Journal of diabetes science and technology, ISSN 1932-2968, 9/2015, Volume 9, Issue 6, pp. 1292 - 1298
insulin infusion set | usage time | skin reactions | insulin pump treatment | Prospective Studies | Humans | Middle Aged | Male | Equipment Design | Hypoglycemic Agents - administration & dosage | Time Factors | Catheters - adverse effects | Adult | Female | Disposable Equipment | Risk Factors | Insulin Infusion Systems - adverse effects | Insulin - administration & dosage | Treatment Outcome | Patient Preference | Biomarkers - blood | Diabetes Mellitus, Type 1 - drug therapy | Infusions, Subcutaneous | Blood Glucose - drug effects | Cross-Over Studies | Diabetes Mellitus, Type 1 - diagnosis | Diabetes Mellitus, Type 1 - blood | Blood Glucose - metabolism | Germany | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
by Brown, Sue A and Kovatchev, Boris P and Raghinaru, Dan and Lum, John W and Buckingham, Bruce A and Kudva, Yogish C and Laffel, Lori M and Levy, Carol J and Pinsker, Jordan E and Wadwa, R. Paul and Dassau, Eyal and Doyle, Francis J and Anderson, Stacey M and Church, Mei Mei and Dadlani, Vikash and Ekhlaspour, Laya and Forlenza, Gregory P and Isganaitis, Elvira and Lam, David W and Kollman, Craig and Beck, Roy W and iDCL Trial Res Grp and iDCL Trial Research Group
The New England journal of medicine, ISSN 0028-4793, 10/2019, Volume 381, Issue 18, pp. 1707 - 1717
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glycated Hemoglobin A - analysis | Blood Glucose - analysis | Pancreas, Artificial - adverse effects | Humans | Middle Aged | Insulin Infusion Systems - adverse effects | Insulin - administration & dosage | Male | Equipment Design | Diabetes Mellitus, Type 1 - drug therapy | Young Adult | Hypoglycemic Agents - administration & dosage | Diabetes Mellitus, Type 1 - blood | Adolescent | Adult | Female | Aged | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Technology application | Dosage and administration | Type 1 diabetes | Patient outcomes | Insulin pumps | Diabetes therapy | Patents | Automation | Royalties | Laboratories | Customization | Diabetes mellitus (insulin dependent) | FDA approval | Glucose | Hypoglycemia | Insulin | Patients | Ketoacidosis | Monitoring systems | Hemoglobin | Software | Diabetes | Kidney diseases | Pancreas | Closed loop systems | Index Medicus | Abridged Index Medicus | Diabetes Mellitus, Type 1/drug therapy | Life Sciences | Human health and pathology | Pancreas, Artificial/adverse effects | Insulin/administration & dosage | Hypoglycemic Agents/administration & dosage | Pharmaceutical sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure
by Halbirk, Mads and Nørrelund, Helene and Møller, Niels and Holst, Jens Juul and Schmitz, Ole and Nielsen, Roni and Nielsen-Kudsk, Jens Erik and Nielsen, Søren Steen and Nielsen, Torsten Toftegaard and Eiskjær, Hans and Bøtker, Hans Erik and Wiggers, Henrik
American journal of physiology. Heart and circulatory physiology, ISSN 0363-6135, 03/2010, Volume 298, Issue 3, pp. H1096 - H1102
Metabolism | Insulin resistance | Nondiabetics | Cardiac & Cardiovascular Systems | Physiology | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiac Output - physiology | Glucagon-Like Peptide 1 - administration & dosage | Humans | Middle Aged | Heart Failure - physiopathology | Male | Insulin - blood | Dose-Response Relationship, Drug | Hypoglycemic Agents - administration & dosage | Heart Rate - physiology | Adult | Female | Blood Pressure - physiology | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Treatment Outcome | Heart Failure - metabolism | Heart Failure - drug therapy | Cross-Over Studies | Exercise Tolerance - physiology | Aged | Infusions, Intravenous | Blood Glucose - metabolism | Glucagon-Like Peptide 1 - adverse effects | Chronic Disease | Hypoglycemic Agents - adverse effects | Glucagon-Like Peptide 1 - therapeutic use | Heart failure | Care and treatment | Analysis | Cardiac patients | Physiological aspects | Hypoglycemic agents | Glucose | Research | Dextrose | Natriuretic peptides | Heart attacks | Peptides | Diabetes | Hypoglycemia | Insulin | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies
by Gibney, Michael and Xue, Zhenyi and Swinney, Monica and Bialonczyk, Damian and Hirsch, Laurence
Diabetes technology & therapeutics, ISSN 1520-9156, 03/2016, Volume 18, Issue 3, pp. 136 - 143
Original Articles | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Catheter Obstruction - adverse effects | Catheterization - methods | Catheterization - instrumentation | Humans | Middle Aged | Specialties, Nursing - education | Insulin Infusion Systems - adverse effects | Male | Materials Testing | Equipment Design | New Jersey | Catheterization - nursing | Young Adult | Pilot Projects | Quality Improvement | Adolescent | Catheters, Indwelling - adverse effects | Adult | Catheterization - adverse effects | Female | Aged | Equipment Failure | Usage | Hyperglycemia | Care and treatment | Insulin pumps | Influence | Diabetes | Risk factors | Studies | Insulin | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Islet transplantation provides superior glycemic control with less hypoglycemia compared with continuous subcutaneous insulin infusion or multiple daily insulin injections
by Holmes-Walker, Deborah Jane and Gunton, Jenny E and Hawthorne, Wayne and Payk, Marlene and Anderson, Patricia and Donath, Susan and Loudovaris, Tom and Ward, Glenn M and Kay, Thomas W.H and O'connell, Philip J
Transplantation, ISSN 0041-1337, 2017, Volume 101, Issue 6, pp. 1268 - 1275
Transplantation | Immunology | Life Sciences & Biomedicine | Surgery | Science & Technology | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Diabetes Mellitus, Type 1 - therapy | Hypoglycemia - prevention & control | Hypoglycemic Agents - administration & dosage | Time Factors | Islets of Langerhans Transplantation - adverse effects | Adult | Female | Insulin Infusion Systems | Hypoglycemia - blood | Hypoglycemia - chemically induced | Drug Administration Schedule | Risk Factors | Insulin - administration & dosage | Treatment Outcome | Biomarkers - blood | Infusions, Subcutaneous | Blood Glucose - drug effects | Diabetes Mellitus, Type 1 - diagnosis | Injections | Diabetes Mellitus, Type 1 - blood | Blood Glucose Self-Monitoring | Australia | Blood Glucose - metabolism | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights